Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:4.1.1.6 (CAD)
 4,420 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Body surface potential mapping (BSPM) is an electrocardiographic measuring technique which produces the data as a series of three-dimensional maps. These maps are assumed to contain information which may help classify subjects for diagnostic purposes more effectively than standard ECGs. As quantitative classification of the complete sequences of maps is complex and cumbersome, the present study uses extracted features which characterise the data. The features, which have been presented and evaluated in a recent work, have been extracted after the maps were processed by a compression technique which conserved the spatial details of the maps. The compression by two-level thresholding converted the sequences of maps into sequences of annuli, from which the following features were extracted: time indices, velocity vector magnitude, loci in three-dimensional space of the centres of mass and cross-correlation coefficients between successive annuli in the sequence. Here, three different classification methods are applied to these features: statistical methods, the Fisher linear discriminant method and visual inspection. BSPMs from 54 subjects are used: 25 normal, 11 WPW syndrome and 18 CAD cases. It is found that by applying a decision role which comprises all features, the procedure offers a completely accurate classification of the subjects to their groups. The three-dimensional centre of mass is found to be the single best classifier; successfully categorising 20/25 of the normals 17/18 of the CAD patients and 11/11 of the WPW patients.
 ...
PMID:Classification of pathologies by reduced sequential potential maps. 164 Jul 51

Our purpose was to assess the efficacy and safety of intravenous ATP for the acute termination of paroxysmal supraventricular tachycardia. There were 14 women and 10 men, aged 38 +/- 15 years. Three patients had evidence of structural heart disease (Ebstein's anomaly associated to atrial septal defect, operated mitral stenosis with insertion of a mechanical heart valve and CAD respectively). Twelve patients had Wolff-Parkinson-White syndrome and another had undergone surgical ablation of an accessory pathway. At the time of electrophysiologic testing, ATP was administered during episodes of paroxysmal supraventricular tachycardia, via a central vein, in incremental doses of 5, 10 and 20 mg followed by a flush of 10 c.c. of isotonic saline. The mechanism of the arrhythmia was orthodromic AV reentrant tachycardia in 19 (79%), AV nodal reentrant tachycardia in 4 (16.6%) and atrial tachycardia in one patient. The mean frequency of the tachycardia was 174 +/- 33 b.p.m. A dose of 5 mg was effective in 16 patients (66%), 5 required 10 mg and two required 20 mg for termination of the tachycardia. In the patient with atrial tachycardia ATP was not effective. The average time after injection to termination of the arrhythmia was 16 +/- 8 seconds. Orthodromic AV reentrant tachycardia was interrupted in the AV node limb in all but one patient and AV nodal reentry was terminated in the "slow-pathway" in three of the four patients. Nine patients had premature ventricular complexes, isolated or in couplets, after the termination of the SVT. Three patients had immediate recurrence of the SVT.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:[Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia]. 804 86